{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:35:12Z","timestamp":1791815712851,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128381","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:07:12Z","timestamp":1771531632000},"page":"128381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Maternal immunization against group B Streptococcus: Immune correlates, microbiome trade-offs, and global implementation challenges"],"prefix":"10.1016","volume":"77","author":[{"given":"Taruna","family":"Ikrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wachyudi","family":"Muchsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfi","family":"Sophian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2026.128381_bb0005","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","article-title":"Prevention of group B streptococcal early-onset disease in newborns","volume":"135","author":"ACOG Committee on Obstetric Practice","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2026.128381_bb0010","first-page":"195","article-title":"Infant antibiotic exposure and childhood overweight","volume":"40","author":"Azad","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128381_bb0015","first-page":"181","article-title":"Protective concentrations of capsular polysaccharide antibodies against group B Streptococcus","volume":"59","author":"Baker","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128381_bb0020","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2020.08.052","article-title":"Group B Streptococcus vaccine candidates","volume":"38","author":"Bianchi-Jassir","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128381_bb0025","first-page":"402","article-title":"Association between maternal antibody levels and risk of invasive group B Streptococcus disease in infants","volume":"61","author":"Dangor","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6429","key":"10.1016\/j.vaccine.2026.128381_bb0030","first-page":"19","article-title":"Role of the microbiome in early-life health","volume":"363","author":"Dominguez-Bello","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128381_bb0035","article-title":"Group B Streptococcus disease during infancy and risk of subsequent neurodevelopmental impairments. Lancet regional health","volume":"48","author":"Fakhraei","year":"2025","journal-title":"Americas"},{"key":"10.1016\/j.vaccine.2026.128381_bb0040","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B Streptococcus infection during pregnancy and infancy","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128381_bb0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S2352-4642(21)00022-5","article-title":"Mortality and neurodevelopmental impairment after invasive group B streptococcal disease","volume":"5","author":"Horv\u00e1th-Puh\u00f3","year":"2021","journal-title":"The Lancet Child & Adolescent Health"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128381_bb0050","first-page":"S15","article-title":"Factors affecting transplacental antibody transfer","volume":"65","author":"Jones","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128381_bb0055","first-page":"3058","article-title":"Functional antibody activity and protection against group B Streptococcus","volume":"37","author":"Kimura","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128381_bb0060","article-title":"Antibiotics in early life and microbiome development","volume":"11","author":"Korpela","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128381_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1471-0528.16852","article-title":"Assessing the added value of maternal immunisation against group B Streptococcus","volume":"129","author":"Lamagni","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2026.128381_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1471-0528.16852","article-title":"Maternal immunisation against GBS","volume":"129","author":"Lamagni","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2026.128381_bb0075","first-page":"7142","article-title":"Defining immune correlates of protection for maternal vaccines","volume":"37","author":"Le Doare","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128381_bb0080","first-page":"S17","article-title":"Antibody kinetics and protection following maternal immunization","volume":"63","author":"Madhi","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128381_bb0085","first-page":"343","article-title":"Safety and immunogenicity of a hexavalent group B Streptococcus conjugate vaccine","volume":"41","author":"Madhi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128381_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258030","article-title":"Burden of invasive group B Streptococcus disease in non-pregnant adults","volume":"16","author":"Navarro-Torn\u00e9","year":"2021","journal-title":"PloS One"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2026.128381_bb0095","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group B Streptococcus worldwide","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128381_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa020205","article-title":"Prevention of perinatal group B streptococcal disease","volume":"347","author":"Schrag","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128381_bb0105","first-page":"e51","article-title":"GBS burden in infants","volume":"17","author":"Seale","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128381_bb0110","first-page":"301","article-title":"Antibiotics and neonatal microbiome disruption","volume":"21","author":"Teuscher","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2026.128381_bb0115","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.vaccine.2023.04.024","article-title":"Vaccine value profile for group B Streptococcus","volume":"41","author":"Trotter","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128381_bb0120","first-page":"130","article-title":"Vaccine hesitancy in pregnancy","volume":"20","author":"Wilson","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128381_bb0125","first-page":"4847","article-title":"WHO preferred product characteristics for group B Streptococcus vaccines","volume":"39","author":"World Health Organization","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128381_bb0130","first-page":"557","article-title":"Antibiotic effects on the human microbiome","volume":"20","author":"Zimmermann","year":"2022","journal-title":"Nat Rev Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:25:51Z","timestamp":1776147951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"alternative-id":["S0264410X26001891"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128381","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal immunization against group B Streptococcus: Immune correlates, microbiome trade-offs, and global implementation challenges","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128381"}}